Kansas City Business Journal: Saint Luke's cardiologist leads trial to see if diabetes drug can prevent serious Covid-19 complications Blue sphere COVID-19 viruses ehohenberg Sat, 04/25/2020 - 11:47

Saint Luke's Mid America Heart Institute and drug company AstraZeneca PLC are conducting a clinical trial to see if a drug now used to treat diabetes could help prevent deadly complications in COVID-19 patients.

The DARE-19 trial involves dapagliflozin, which is marketed in the United States as Farxiga and can reduce blood glucose levels in diabetes patients. The double-blind trial follows previous research indicating that the drug also may provide some protection to the heart and kidney for high-risk patients. Patients with conditions like diabetes, heart disease and kidney disease are at higher risk of complications or death due to COVID-19.

The trial will involve 900 patients in the U.S. and globally, said Dr. Mikhail Kosiborod, a cardiologist with the Saint Luke's Mid America Heart Institute and principal investigator for the trial.

Read the full Kansas City Business Journal article: Saint Luke's cardiologist leads trial to see if diabetes drug can prevent serious Covid-19 complications

Organizations

Saint Luke's Mid America Heart Institute

News Serviceline Category

Research Heart

Read more

Related Content

Apparel, Clothing, Coat, Lab Coat, Person, Doctor
Danielle's story

"You get those rare moments that you're reminded why you went into this field, and it makes everything so much better." Danielle Hammontree, Certified Family Nurse Practitioner, Saint Luke’s East Hospital

Read more
Person, Doctor, Clothing, Apparel, Lab Coat, Coat, Face, Nurse
Deb's story

Deb Day, Registered Nurse · Anderson County Hospital "I am a Saint Luke's Nurse.  Nurses are the lifeblood of Saint Luke’s compassionate care, and the life-changing work they do is...

Read more
Person, Hair, Nurse, Face, Female, Word
Nicole's story

"What we do is so vital. We have so much power as nurses." Nicole Roberson, Registered Nurse, Neuroscience ICU, Saint Luke's Hospital of Kansas City

Read more